Original Source(s)
Related Content
FDA Grants Traditional Approval to Iptacopan in Primary IgAN
Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.
July 17, 2026
-
2 min
Does High PCT Warrant Longer Therapy?
In a planned BALANCE analysis, elevated day 7 procalcitonin was associated with higher mortality, but the small subgroup analysis found no evidence that extending antibiotics from 7 to 14 days improved outcomes.
July 15, 2026
-
4 min
Can LAI-CAB Sustain Long-Term PrEP Use?
A national claims analysis found modest uptake and declining persistence over 2 years despite increasing use of injectable HIV pre-exposure prophylaxis.
July 17, 2026
-
4 min